Icon

APADAZ (nda208653)- (325MG;EQ 6.12MG BASE,325MG;EQ 4.08MG BASE,325MG;EQ 8.16MG BASE)

ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE ZEVRA THERAP
325MG;EQ 6.12MG BASE,325MG;EQ 4.08MG BASE,325MG;EQ 8.16MG BASE
No Yes
2031-Feb-22 Expired
None None
None No
APADAZ is a combination of benzhydrocodone, a prodrug of the opioid agonist hydrocodone, and acetaminophen, and is indicated for the short-term (no more than 14 days) management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
0 0 0
Total Other Developers None
Drugs with Suitability No
325MG;EQ 6.12MG BASE ** ** - - -
325MG;EQ 4.08MG BASE ** ** - - -
325MG;EQ 8.16MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.